Gateway Investment Advisers’s Bio-Rad Laboratories Class A BIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,158
| Closed | -$380K | – | 508 |
|
|
2024
Q4 | $380K | Buy |
1,158
+373
| +48% | +$123K | ﹤0.01% | 410 |
|
|
2024
Q3 | $263K | Sell |
785
-90
| -10% | -$30.1K | ﹤0.01% | 466 |
|
|
2024
Q2 | $239K | Sell |
875
-39
| -4% | -$10.7K | ﹤0.01% | 470 |
|
|
2024
Q1 | $316K | Sell |
914
-21
| -2% | -$7.26K | ﹤0.01% | 438 |
|
|
2023
Q4 | $302K | Sell |
935
-140
| -13% | -$45.2K | ﹤0.01% | 436 |
|
|
2023
Q3 | $385K | Buy |
1,075
+44
| +4% | +$15.8K | ﹤0.01% | 406 |
|
|
2023
Q2 | $391K | Buy |
1,031
+381
| +59% | +$144K | ﹤0.01% | 405 |
|
|
2023
Q1 | $311K | Buy |
650
+114
| +21% | +$54.6K | ﹤0.01% | 436 |
|
|
2022
Q4 | $225K | Buy |
+536
| New | +$225K | ﹤0.01% | 504 |
|
|
2022
Q3 | – | Sell |
-912
| Closed | -$451K | – | 512 |
|
|
2022
Q2 | $451K | Buy |
912
+307
| +51% | +$152K | 0.01% | 433 |
|
|
2022
Q1 | $341K | Hold |
605
| – | – | ﹤0.01% | 476 |
|
|
2021
Q4 | $457K | Buy |
605
+54
| +10% | +$40.8K | ﹤0.01% | 429 |
|
|
2021
Q3 | $411K | Buy |
551
+63
| +13% | +$47K | ﹤0.01% | 436 |
|
|
2021
Q2 | $314K | Sell |
488
-13
| -3% | -$8.37K | ﹤0.01% | 476 |
|
|
2021
Q1 | $286K | Buy |
501
+5
| +1% | +$2.85K | ﹤0.01% | 483 |
|
|
2020
Q4 | $289K | Sell |
496
-21
| -4% | -$12.2K | ﹤0.01% | 477 |
|
|
2020
Q3 | $266K | Buy |
517
+51
| +11% | +$26.2K | ﹤0.01% | 470 |
|
|
2020
Q2 | $210K | Buy |
+466
| New | +$210K | ﹤0.01% | 510 |
|